Istanbul

DSCN6033 DSCN6036DSCN6040 DSCN6063 DSCN6069   DSCN6067DSCN6070 DSCN6105 DSCN6118 DSCN6027

In Istanbul. What an amazing city, every time I come here I am still amazed, at its size, modernity, ancient history, architecture and scenery, not to mention the food.

The first day, had anxiety attacks, almost to the point of panic. Ah yes, you can leave the place behind, but you cannot leave your brain behind. powered through them though, after spending all morning sobbing in my room, went about the rest of the day with aplomb, hahaha.

Today, I feel fine. Maybe it was the time change that brought on the anxiety. Still have many periods of dizziness, that’s how I manifest jet lag. oh and I have a sinus infection, rare for me, and luckily I was able to get Zithromax without a prescription, don’t need one in Turkey. So, I am hoping that my sinus headache will be gone in a day or two.

On the positive side, Istanbul is beautiful, the Bosphorus is a deep blue, the weather is perfect and it is lovely to be with my family here, in this gorgeous city.

A bit up…

IMG_1793

Feeling a bit up today. Coffee/ caffeine is having its heart pounding, overly talkative effect on me again. That only happens when I am having an up swing. Time to bring out the big gun, increase my Lithium dose. I am in a play, a musical actually. A bit of a chaotic mess at rehearsals, that has me very anxious and sort of dreading them. I am also going to Istanbul, Turkey day after tomorrow, excited and a bit anxious about that. And of course, June 21st, every year, at this time, we feel the loss of my beloved brother Farooq acutely. All this anxiety will definitely push me into either an up or down swing, and up it is. Jumpy, irritable, anxious, talkative, intense, passionate, that is how I am feeling. A bit manic, or is this the real me? Oh god, please let’s not start that again… Being manicky is probably easier on me and much more difficult for other people to handle, because there is so much “more” of me than normal. I might be in your face, I might be very vocal, I will definitely be extremely intense and passionate, hard for people to handle, sometimes even I tell myself to just shut up, lol. Being depressed is much more painful and difficult for me to handle, however, it is much easier for other people to handle a depressed me, because there is so much “less” of me in my depressed state. I would be quiet as a mouse, tired, sleepy, just a sad, watered down version of myself. But easier for everyone else to handle.

Anyway, I’m up right now, so have to get back to my normal, less anxious, less up state, haha I said up state, as in Upstate NY. Ooops here come the flight of ideas, another symptom of manicness… Ok, a few days of some increased lithium and I will stop this in it’s tracks, because I really don’t have time for all this BS right now. Have to be functional, calm, and in control. Must do a good job in the play and must be normal in Turkey. That’s all there is to it. Wish me luck, oh and lithium 🙂

Mindfulness practice leads to increases in regional brain gray matter density

IMG_1661 IMG_3618

Thank you Kitt, (kittomalley.com) for posting this on your FB page! This is big, very big.

Of course it’s known that meditation has tremendous benefits for practitioners. Now, a study called “Mindfulness practice leads to increases in regional brain gray matter density” by Hölzel et al, shows how and why. In this Harvard study, they took participants who did Mindfulness meditation 27 minutes per day, for eight weeks and controls who did not meditate. They then took MRI’s of their brains and looked for differences. In the group that practiced mindfulness meditation, the areas in the hippocampus had a major increase in gray matter. The hippocampus is part of the Limbic system, the region in the brain that regulates emotions. They also saw a decrease in the gray matter of the amygdala, the area in the brain that is responsible for stress and anxiety. Therefore, “The results suggest that participation in MBSR is associated with changes in gray matter concentration in brain regions involved in learning and memory processes, emotion regulation, self-referential processing, and perspective taking.”

So it has now been shown how meditation works! It seems like the perfect thing to do if you have a mood disorder! Will you meditate? Well that’s up to you. For myself, yes. I am starting today.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004979/

Brain Inflammation triggered by Chronic Pain Linked to Depression and Anxiety

MICRO

Brain inflammation caused by chronic nerve pain alters activity in regions that regulate mood and motivation. This, for the first time, shows a direct biophysical link exists between long-term pain and the depression, anxiety and substance abuse seen in more than half of these patients.

These findings also point the way to new treatment options for those with chronic pain, the incidence of suicide in patients with chronic pain is second only to those with bipolar d/o. Therefore it would be wonderful to have new treatments.

Researchers found that that pain-derived brain inflammation causes the accelerated growth and activation of immune cells called microglia. These cells trigger chemical signals within neurons that restrict the release of dopamine, a neurotransmitter that helps control the brain’s reward and pleasure centers.

Morphine and its derivatives can be ineffective in treating chronic pain. This study explains why, normally morphine and its derivatives stimulate the release of dopamine, but in rats with chronic pain, administration of morphine does not cause them to produce dopamine, resulting in impaired reward-motivated behavior. However, when these rats are treated with drugs that inhibit microglial activation, they then start producing dopamine.

Next the researchers aim to look at human chronic pain, and determine whether pain derived behaviors might account for mood disorders in these patients.

This can also shed light on mood disorders that are not caused by chronic pain. Of course dopamine is an integral part of the neurotransmitter system that contributes to mood stability. It is also the main neurotransmitter involved in Parkinson’s disease. Hoping for good things to come out of this research.

_________________________________________________________________________________

Article reference below:

Microglia Disrupt Mesolimbic Reward Circuitry in Chronic Pain

http://www.jneurosci.org/content/35/22/8442.full.pdf+html

Noninvasive brain stimulator may ease parkinson’s symptoms in a patient’s homeParkinson’s disease

Master’s students have developed a new portable device to inhibit neuronal firing in critical regions of the brains of people with Parkinson’s disease to stop the tremors associated with that disease. This device is a helmet, which the patient can control, it sends electrical stimulation to the patient’s brain, however the level and duration of the stimulation is controlled by a physician.

The wonderful part about this is that it is portable and under the patient’s control. My father in law had Parkinson’s disease, he was a solid, strong, silent man, and this disease brought him down like tissue paper fluttering from the sky. I’m sure at least some of his symptoms and problems would have been alleviated by this portable helmet!

Article and reference below.

http://www.neuroscientistnews.com/clinical-updates/noninvasive-brain-stimulator-may-ease-parkinson-s-symptoms-patient-s-home

Parkinson’s disease patients whose symptoms such as tremor, muscle stiffness and slowed movement make it tough to hold an eating utensil steady have few options for relief outside of a hospital or clinic. Medication can help, but over time it tends to become less effective. To give these patients another in-home option, Johns Hopkins graduate students have invented a headband-shaped device to deliver noninvasive brain stimulation to help tamp down the symptoms.

The students’ prototype, developed during a yearlong biomedical engineering master’s degree program, has not yet been tested on humans, but it is viewed as a promising first step toward helping Parkinson’s patients safely relieve their own symptoms at home or elsewhere without going to a hospital or doctor’s office. The design has already received recognition at several prominent competitions. On June 9, it won the $5,000 second-place prize in VentureWell’s BMEidea national design contest for biomedical and bioengineering students. In May, the invention earned first-place honors in the People’s Choice Award competition at Johns Hopkins’ Biomedical Engineering Design Day 2015. Earlier, it was a finalist in the Rice University Business Plan Competition.

The five student team members were inspired to build the new device last summer after observing neurosurgery being performed on Parkinson’s patients at Johns Hopkins Hospital. Parkinson’s is an incurable neurodegenerative disorder that affects 1 million people in the United States and 7 million worldwide.

Tremtex team members
From left, the Tremtex team members are Ian Graham, Melody Tan, Erin Reisfeld, Shruthi Rajan and David Blumenstyk. Credit: Will Kirk, Johns Hopkins University

For patients in advanced stages, one treatment option is deep brain stimulation. In this procedure, a surgeon implants thin electrical leads into the region of the brain that controls movement. The leads are connected to a pulse generator—similar to a pacemaker for the heart—that is placed under the skin below the collarbone. This implant sends electrical signals to the brain to help curb some symptoms caused by Parkinson’s.

“We saw that this procedure is really invasive and can take 10 to 15 hours to complete,” said Shruthi Rajan, a team member from Charlotte, North Carolina. “It’s also very expensive, and not all patients qualify for the surgery. We asked if there was a way to provide the same treatment in a less invasive way that doesn’t require brain surgery.”

The students were referred to Yousef Salimpour, a Johns Hopkins Medicine postdoctoral research associate who has been studying a noninvasive Parkinson’s therapy called transcranial direct current stimulation. In this painless treatment, low-level current is passed through two electrodes placed over the head to tweak the electrical activity in specific areas of the brain. The technique can be used to excite or inhibit these nerve cells. The treatment is still considered experimental, but it has attracted much attention because it does not require surgery and is inexpensive, safe and relatively easy to administer without any side effects.

The biomedical engineering students met with Salimpour to learn about the research he conducts in a clinical setting. “We told him we had an idea for a portable home version of this equipment,” Rajan said. “But we planned to add safety measures to make sure the patient used it properly without a doctor or nurse being present.”

The students aimed for a prototype that would enable a patient to activate the battery-powered treatment by touching a large easy-to-press button. With patient safety in mind, the students designed their prototype to deliver current for only 20 minutes daily and only at a doctor-prescribed level.

To help fine-tune their design, the students met with dozens of Parkinson’s patients over a four-month period. Although the students did not administer the actual brain treatment, the patients help them craft the critical headband component so that it would be easy to put on, comfortable to wear and positioned so that the electrodes would remain stable and properly target the motor cortices areas of the brain.

“For a comfortable fit, we put an elastic band in the back and told the patients to put it on like a baseball cap,” said team member Ian Graham, from Old Saybrook, Conn. “The interaction with the patients was really helpful. In our usual college classes, we’re just given a textbook problem to solve. In this program, being able to find a real-life biomedical problem and figure out how to address it was huge. And we even received letters of encouragement from some of the patients we met.”

The other members of the student design team were David Blumenstyk, Erin Reisfeld and Melody Tan.

In addition to the assistance from neuroengineer Salimpour, the student inventors received guidance from other members of an interdisciplinary team of Johns Hopkins medical researchers that includes neurologist Zoltan Mari, neurosurgeon William Anderson and neuroscientist Reza Shadmehr.

“Our group is working on the idea of using noninvasive brain stimulation for Parkinson’s disease symptom control as a new clinical treatment,” Salimpour said. “Our preliminary results were promising. Patients keep asking us for more of this treatment. But we couldn’t provide the treatment for them because there is no portable and FDA-approved device like this for Parkinson’s patients that is on the market at this time. The biomedical engineering students then approached us with the idea of designing the home-based treatment device. They did a great job, and made a fascinating prototype. We hope that based on their preliminary work, Parkinson’s patients will receive the benefit of this new technique at home very soon.”

With help from the Johns Hopkins Technology Ventures staff, the student inventors obtained provisional patents covering the design of the device, dubbed the STIMband. Another Johns Hopkins student team is slated to take over the project in September to further enhance the design and move it closer to patient availability. One addition may be a wireless connection to allow a doctor to adjust a home patient’s treatment level from a remote location.

– See more at: http://www.neuroscientistnews.com/clinical-updates/noninvasive-brain-stimulator-may-ease-parkinson-s-symptoms-patient-s-home#sthash.1LZh448E.dpuf

Antihistamine Decreases Schizophrenia Symptoms (!!!)

change in sx

This is major, in a study in Finland, (link below) giving 200 mg of an antihistamine called famotidine  to patients with treatment resistant schizophrenia reported decreased symptoms in a week and in a month had statistically significant decreases in their symptoms!

The drug penetrated the blood brain barrier and effectively blocked histamine from binding the H2 receptors, and this drug affected signaling molecules shown to be involved in schizophrenia.

If this works for all people with schizophrenia, it will be a godsend! Then the awful antipsychotic medications, with their awful, awful, side effects, may not have to be used, or may be used in reduced doses.

This may also work for people with bipolar d/o, when they are in a psychotic (out of touch with reality) phase.

This is so amazing! That something so mundane as an antihistamine can actually treat a complicated and awful disease such as schizophrenia! This shows the power of biological/medical research, how discoveries can change treatment of horrible diseases for the better and improve the quality of life of people who suffer from such diseases.

http://www.eurekalert.org/pub_releases/2013-07/uoh-ntf070113.php

Study on nematode model of ALS offers new treatment hope

Stephen Hawking

This is amazing! It has been found that in amyotrophic lateral sclerosis (ALS), the disease that Stephen Hawking has, the immune system system attacks and kills motor neurons. They used a worm called Caenorhabditis elegans (C. elegans) and introduced a mutated human gene (TDP-43 or FUS) into C. elegans, a nematode worm widely used for genetic experiments. The worms became paralyzed within about 10 days. Then in an effort to save the worm, they introduced a mutated immune gene gene called tir-1.  “Worms with an immune deficit resulting from the tir-1 gene’s mutation were in better health and suffered far less paralysis.”

So a mutation in an immune gene that leads to less immune function leads to less killing of motor neurons and far more healthy and less paralyzed worms! Amazing!

In my humble opinion, the immune system is involved in FAR MORE diseases than we know. I believe the immune system is involved in mental illnesses as well. That is why I am always keeping an eye on Immunological involvement in Neurological and or Mental illnesses.

http://www.neuroscientistnews.com/research-news/study-nematode-model-als-offers-new-treatment-hope

And what about dog lovers? Well…

They have more one night stands! Hahaha!

http://www.torontosun.com/2013/08/12/dog-lovers-more-likely-to-have-one-night-stands-survey

Many cat lovers play hard to get and dog owners often have friends with benefits, but pet-free Canadians are the saddest among us when it comes romance, a new survey has found.

The survey of Canadians on Match.com examines the dating behaviour of people based on their pet preferences.

Cat lovers, it found, are frugal, shelling out just $5 to $20 on a first date. Dog owners, meanwhile, are more generous, spending an average of $40 to $50.

Cat lovers are also quite aloof, with 34% waiting for the other person to make contact after a first date.

At 55%, dog people are the most likely to have had a one-night stand. They are also the most likely to have dated a friend, 51% compared 47% of cat lovers.

But it’s the pet-free Canadians who lack that romantic spark. At 68%, they are the least likely to believe in soulmates and true love, compared to 77% of dog lovers and 76% of cat lovers.

The survey of 1,054 Canadian singles was conducted Aug. 29-Sept. 1, 2012.

I Don’t Understand

I Don’t Understand

Why do young men with more melanin in their skin get killed, by police, by each other

I Don’t Understand

Why there is less opportunity for “people of color”

I Don’t Understand

Are we not all of the same human race?

Why this discrimination, why this disgrace?

I Don’t Understand

Why are women raped?

Are we not your sisters, your mothers, your daughters?

How, then, on us, can you lay a hand?

I Don’t Understand

People are starving, they have nothing to eat

While others gorge themselves till they are obese?

The earth is dying, we don’t give a care

Temperatures increasing, icebergs decreasing, deforestation, species elimination

I Don’t Understand

Oh, animal abuse, I can’t even talk about it

These innocent beings, cats, dogs, horses, others, can’t even talk about it

I Don’t Understand

Can we not live in a gentler world?

Where resources are shared and the earth is not raped?

Where we live as brothers and sisters and cooperate?

Where the color of our skin gives us no advantages or disadvantages?

Where no one has to say “Black Lives Matter”, and 2000 girls in Nigeria live safe and sound

And the only thing Isis signifies is the name of the Goddess who was the daughter of the Earth and the sky

Tell me why this world cannot be?

If each of us tries, if each of us thinks, if each of us acts

I Don’t Understand

Why it can’t

STIGMA…?

I have to write about stigma, I hear this word often in conjunction with mental illness, any kind of mental illness. People are afraid of stigma, so they won’t get treatment, they won’t take medication, they won’t see a therapist, they won’t disclose that they have a mental illness to their boss, they won’t tell anyone because people will call them crazy, people will be afraid of them. Yes, this is all the case. But why does stigma exist? Why are people called crazy? Why are others afraid of them? Why won’t they disclose that they have a mental illness? Well, when we are ill, in a severe phase of a mental illness, when we are out of touch with reality, we are indeed “crazy”. I don’t mean to offend anyone, but I know that I have thought that a witch with black magic powers was trying to literally destroy my heart, and this witch lived in Eastern Europe. Yes I really did think that in the midst of a severe, full blown manic phase. I would now consider this sort of crazy… ummm…sorry but I would. So there’s that stigma, sort of correctly placed on the severely mentally ill. Also why do people fear us? Well, we are capable of doing some truly awful things in the throes of mental illness, see Adam Lanza in Sandy Hook. Of course most mentally ill people do not commit any crimes and are not violent, and most crimes and violence is committed by “normal” people, that being said, people are still not sure what to expect of people with mental illness, and uncertainty can be frightening. So there it is, the reasons for stigma.

So how do we combat stigma? We get treatment from a psychiatrist and psychologist. We take our medication, faithfully. We do all the things we know keep us in the healthy zone like exercise, yoga, meditation. We stay normal. We don’t visit the crazy place, we don’t go there, we stay away from it. And then if we tell people we have bipolar d/o or depression, or anxiety, they see that we are “normal” and they have nothing to fear from us, or be uncomfortable about. And voila! The end of stigma, at least the beginning of the end.